메뉴 건너뛰기




Volumn 58, Issue 2, 2014, Pages 1167-1178

Reversible cysteine protease inhibitors show promise for a chagas disease cure

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CRUZIPAIN INHIBITOR; CYCLOPHOSPHAMIDE; CYSTEINE PROTEINASE INHIBITOR; CZ 001; CZ 002; CZ 003; CZ 005; CZ 007; CZ 008; NITRILE; ODANACATIB; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

EID: 84893484984     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01855-13     Document Type: Article
Times cited : (82)

References (58)
  • 2
    • 77954187759 scopus 로고    scopus 로고
    • Chagas disease: A new worldwide challenge
    • Coura JR, Vinas PA. 2010. Chagas disease: a new worldwide challenge. Nature 465:S6-S7. http://dx.doi.org/10.1038/nature09221.
    • (2010) Nature , vol.465
    • Coura, J.R.1    Vinas, P.A.2
  • 3
    • 0142197130 scopus 로고    scopus 로고
    • Chagas disease: Current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries
    • Moncayo A. 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 98:577-591. http://dx.doi.org/10.1590/S0074- 02762003000500001.
    • (2003) Mem. Inst. Oswaldo Cruz , vol.98 , pp. 577-591
    • Moncayo, A.1
  • 4
    • 27744577051 scopus 로고    scopus 로고
    • High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina
    • Negrette OS, Mora MC, Basombrio MA. 2005. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 115:e668-e672. http://dx.doi.org/10.1542/peds.2004-1732.
    • (2005) Pediatrics , vol.115
    • Negrette, O.S.1    Mora, M.C.2    Basombrio, M.A.3
  • 5
    • 77953023715 scopus 로고    scopus 로고
    • Chagas disease in Spain, the United States and other non-endemic countries
    • Gascon J, Bern C, Pinazo MJ. 2010. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 115:22-27. http://dx.doi.org/10.1016/j.actatropica.2009.07.019.
    • (2010) Acta Trop. , vol.115 , pp. 22-27
    • Gascon, J.1    Bern, C.2    Pinazo, M.J.3
  • 9
    • 79959793199 scopus 로고    scopus 로고
    • Antitrypanosomal therapy for chronic Chagas' disease
    • Bern C. 2011. Antitrypanosomal therapy for chronic Chagas' disease. N. Engl. J. Med. 364:2527-2534. http://dx.doi.org/10.1056/NEJMct11014204.
    • (2011) N. Engl. J. Med. , vol.364 , pp. 2527-2534
    • Bern, C.1
  • 10
    • 77955436769 scopus 로고    scopus 로고
    • New insights in Chagas' disease treatment
    • Urbina JA. 2010. New insights in Chagas' disease treatment. Drugs Future 35:409-419. http://dx.doi.org/10.1358/dof.2010.035.05.1484391.
    • (2010) Drugs Future , vol.35 , pp. 409-419
    • Urbina, J.A.1
  • 11
    • 79952059363 scopus 로고    scopus 로고
    • Current and developing therapeutic agents in the treatment of Chagas disease
    • Apt W. 2010. Current and developing therapeutic agents in the treatment of Chagas disease. Drug Des. Devel. Ther. 4:243-253. http://dx.doi.org/10.2147/ DDDT.58338.
    • (2010) Drug Des. Devel. Ther. , vol.4 , pp. 243-253
    • Apt, W.1
  • 14
    • 0036234361 scopus 로고    scopus 로고
    • Chemotherapy of Chagas disease
    • Urbina JA. 2002. Chemotherapy of Chagas disease. Curr. Pharm. Des. 8:287-295. http://dx.doi.org/10.2174/1381612023396177.
    • (2002) Curr. Pharm. Des. , vol.8 , pp. 287-295
    • Urbina, J.A.1
  • 15
    • 0032781317 scopus 로고    scopus 로고
    • Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action
    • McKerrow JH. 1999. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action. Int. J. Parasitol. 29:833-837.
    • (1999) Int. J. Parasitol. , vol.29 , pp. 833-837
    • McKerrow, J.H.1
  • 16
    • 0036835142 scopus 로고    scopus 로고
    • Proteinases of Trypanosoma cruzi: Patential targets for the chemotherapy of Chagas desease
    • Cazzulo JJ. 2002. Proteinases of Trypanosoma cruzi: patential targets for the chemotherapy of Chagas desease. Curr. Top. Med. Chem. 2:1261-1271. http://dx.doi.org/10.2174/1568026023392995.
    • (2002) Curr. Top. Med. Chem. , vol.2 , pp. 1261-1271
    • Cazzulo, J.J.1
  • 17
    • 82755198904 scopus 로고    scopus 로고
    • The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
    • Alvarez VE, Niemirowicz GT, Cazzulo JJ. 2012. The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death. Biochim. Biophys. Acta 1824: 195-206. http://dx.doi.org/10.1016/j.bbapap.2011.05.011.
    • (2012) Biochim. Biophys. Acta , vol.1824 , pp. 195-206
    • Alvarez, V.E.1    Niemirowicz, G.T.2    Cazzulo, J.J.3
  • 18
    • 80053308901 scopus 로고    scopus 로고
    • Cruzain: The path from target validation to the clinic
    • Sajid M, Robertson SA, Brinen LS, McKerrow JH. 2011. Cruzain: the path from target validation to the clinic. Adv. Exp. Med. Biol. 712:100-115. http://dx.doi.org/10.1007/978-1-4419-8414-2-7.
    • (2011) Adv. Exp. Med. Biol. , vol.712 , pp. 100-115
    • Sajid, M.1    Robertson, S.A.2    Brinen, L.S.3    McKerrow, J.H.4
  • 19
    • 80053321084 scopus 로고    scopus 로고
    • Cysteine peptidases of kinetoplastid parasites
    • Caffrey CR, Lima AP, Steverding D. 2011. Cysteine peptidases of kinetoplastid parasites. Adv. Exp. Med. Biol. 712:84-99. http://dx.doi.org/10. 1007/978-1-4419-8414-2-6.
    • (2011) Adv. Exp. Med. Biol. , vol.712 , pp. 84-99
    • Caffrey, C.R.1    Lima, A.P.2    Steverding, D.3
  • 20
    • 0032541311 scopus 로고    scopus 로고
    • Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection
    • Engel JC, Doyle PS, Hsieh I, McKerrow JH. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734.
    • (1998) J. Exp. Med. , vol.188 , pp. 725-734
    • Engel, J.C.1    Doyle, P.S.2    Hsieh, I.3    McKerrow, J.H.4
  • 21
    • 35848971033 scopus 로고    scopus 로고
    • A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
    • Doyle PS, Zhou YM, Engel JC, McKerrow JH. 2007. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Antimicrob. Agents Chemother. 51:3932-3939. http://dx.doi.org/10.1128/AAC.00436- 07.
    • (2007) Antimicrob. Agents Chemother. , vol.51 , pp. 3932-3939
    • Doyle, P.S.1    Zhou, Y.M.2    Engel, J.C.3    McKerrow, J.H.4
  • 24
    • 33749664751 scopus 로고    scopus 로고
    • The consequences of lysosomotropism on the design of selective cathepsinKinhibitors
    • Black WC, Percival MD. 2006. The consequences of lysosomotropism on the design of selective cathepsinKinhibitors. Chembiochem 7:1525-1535. http://dx.doi.org/10.1002/cbic.200600149.
    • (2006) Chembiochem , vol.7 , pp. 1525-1535
    • Black, W.C.1    Percival, M.D.2
  • 28
    • 84859293501 scopus 로고    scopus 로고
    • Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease
    • Nicoll-Griffith DA. 2012. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease. Expert Opin. Drug Discov. 7:353-366. http://dx.doi.org/10.1517/17460441.2012.668520.
    • (2012) Expert Opin. Drug Discov. , vol.7 , pp. 353-366
    • Nicoll-Griffith, D.A.1
  • 32
    • 0026781519 scopus 로고
    • The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi
    • Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS. 1992. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J. Biol. Chem. 267:7411-7420.
    • (1992) J. Biol. Chem. , vol.267 , pp. 7411-7420
    • Eakin, A.E.1    Mills, A.A.2    Harth, G.3    McKerrow, J.H.4    Craik, C.S.5
  • 35
    • 0035912807 scopus 로고    scopus 로고
    • L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: Contribution of the nitric oxide and polyamine pathways
    • Piacenza L, Peluffo G, Radi R. 2001. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Proc. Natl. Acad. Sci. U. S. A. 98:7301-7306. http://dx.doi.org/10. 1073/pnas.121520398.
    • (2001) Proc. Natl. Acad. Sci. U. S. A. , vol.98 , pp. 7301-7306
    • Piacenza, L.1    Peluffo, G.2    Radi, R.3
  • 36
    • 32344432042 scopus 로고    scopus 로고
    • Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease
    • Berrizbeitia M, Ndao M, Bubis J, Gottschalk M, Ache A, Lacouture S, Medina M, Ward BJ. 2006. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease. J. Clin. Microbiol. 44:291-296. http://dx.doi.org/10.1128/JCM.44.2.291-296.2006.
    • (2006) J. Clin. Microbiol. , vol.44 , pp. 291-296
    • Berrizbeitia, M.1    Ndao, M.2    Bubis, J.3    Gottschalk, M.4    Ache, A.5    Lacouture, S.6    Medina, M.7    Ward, B.J.8
  • 37
    • 0035871948 scopus 로고    scopus 로고
    • Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: Application of robotic sample preparation and fast liquid chromatography-mass spectrometry
    • Bateman KP, Castonguay G, Xu L, Rowland S, Nicoll-Griffith DA, Kelly N, Chan CC. 2001. Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 754:245-251.
    • (2001) J. Chromatogr. B Biomed. Sci. Appl. , vol.754 , pp. 245-251
    • Bateman, K.P.1    Castonguay, G.2    Xu, L.3    Rowland, S.4    Nicoll-Griffith, D.A.5    Kelly, N.6    Chan, C.C.7
  • 38
    • 16544390350 scopus 로고    scopus 로고
    • Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (epimastigotes, amastigotes, and trypomastigotes) and assessment of antigen stability for the three assays
    • Berrizbietia M, Ndao M, Gottschalk M, Ache A, Vasquez F, Lacouture S, Medina M, Ward BJ. 2004. Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (epimastigotes, amastigotes, and trypomastigotes) and assessment of antigen stability for the three assays. J. Clin. Microbiol. 42:1766-1769. http://dx.doi.org/10.1128/JCM.42.4.1766-1769.2004.
    • (2004) J. Clin. Microbiol. , vol.42 , pp. 1766-1769
    • Berrizbietia, M.1    Ndao, M.2    Gottschalk, M.3    Ache, A.4    Vasquez, F.5    Lacouture, S.6    Medina, M.7    Ward, B.J.8
  • 39
    • 0017168578 scopus 로고
    • Trypanosoma brucei: A rapid "matching" method for estimating the host's parasitemia
    • Herbert WJ, Lumsden WH. 1976. Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. Exp. Parasitol. 40:427-431.
    • (1976) Exp. Parasitol. , vol.40 , pp. 427-431
    • Herbert, W.J.1    Lumsden, W.H.2
  • 40
    • 43249116465 scopus 로고    scopus 로고
    • Drug-induced cure drives conversion to a stable and protective CD8 T central memory response in chronic Chagas disease
    • Bustamante JM, Bixby LM, Tarleton RL. 2008. Drug-induced cure drives conversion to a stable and protective CD8 T central memory response in chronic Chagas disease. Nat. Med. 14:542-550. http://dx.doi.org/10.1038/nm1744.
    • (2008) Nat. Med. , vol.14 , pp. 542-550
    • Bustamante, J.M.1    Bixby, L.M.2    Tarleton, R.L.3
  • 41
    • 0034503184 scopus 로고    scopus 로고
    • Trypanosoma cruzi infection of squirrel monkeys: Comparison of blood smear examination, commercial enzymelinked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries
    • Ndao M, Kelly N, Normandin D, Maclean JD, Whiteman A, Kokoskin E, Arevalo I, Ward BJ. 2000. Trypanosoma cruzi infection of squirrel monkeys: comparison of blood smear examination, commercial enzymelinked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries. Comp. Med. 50:658-665.
    • (2000) Comp. Med. , vol.50 , pp. 658-665
    • Ndao, M.1    Kelly, N.2    Normandin, D.3    Maclean, J.D.4    Whiteman, A.5    Kokoskin, E.6    Arevalo, I.7    Ward, B.J.8
  • 43
    • 77952497845 scopus 로고    scopus 로고
    • Hurdles in the drug discovery of cathepsin K inhibitors
    • Kometani M, Nonomura K, Tomoo T, Niwa S. 2010. Hurdles in the drug discovery of cathepsin K inhibitors. Curr. Top. Med. Chem. 10:733-744. http://dx.doi.org/10.2174/156802610791113478.
    • (2010) Curr. Top. Med. Chem. , vol.10 , pp. 733-744
    • Kometani, M.1    Nonomura, K.2    Tomoo, T.3    Niwa, S.4
  • 46
    • 2542533103 scopus 로고    scopus 로고
    • Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi
    • Greenbaum DC, Mackey Z, Hansell E, Doyle P, Gut J, Caffrey CR, Lehrman J, Rosenthal PJ, McKerrow JH, Chibale K. 2004. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J. Med. Chem. 47:3212-3219. http://dx.doi.org/10.1021/jm030549j.
    • (2004) J. Med. Chem. , vol.47 , pp. 3212-3219
    • Greenbaum, D.C.1    Mackey, Z.2    Hansell, E.3    Doyle, P.4    Gut, J.5    Caffrey, C.R.6    Lehrman, J.7    Rosenthal, P.J.8    McKerrow, J.H.9    Chibale, K.10
  • 49
    • 0026606269 scopus 로고
    • Inhibitors of the major cysteinyl proteinase (GP57/ 51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro
    • Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, Murta AC, Scharfstein J. 1992. Inhibitors of the major cysteinyl proteinase (GP57/ 51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 52:175-184.
    • (1992) Mol. Biochem. Parasitol. , vol.52 , pp. 175-184
    • Meirelles, M.N.1    Juliano, L.2    Carmona, E.3    Silva, S.G.4    Costa, E.M.5    Murta, A.C.6    Scharfstein, J.7
  • 50
    • 0031937742 scopus 로고    scopus 로고
    • Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi
    • Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow JH. 1998. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J. Cell Sci. 111:597-606.
    • (1998) J. Cell Sci. , vol.111 , pp. 597-606
    • Engel, J.C.1    Doyle, P.S.2    Palmer, J.3    Hsieh, I.4    Bainton, D.F.5    McKerrow, J.H.6
  • 51
    • 4644357065 scopus 로고    scopus 로고
    • A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes
    • Aparicio IM, Scharfstein J, Lima AP. 2004. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 72:5892-5902. http://dx.doi.org/10.1128/IAI.72.10. 5892-5902.2004.
    • (2004) Infect. Immun. , vol.72 , pp. 5892-5902
    • Aparicio, I.M.1    Scharfstein, J.2    Lima, A.P.3
  • 54
    • 84874310959 scopus 로고    scopus 로고
    • The kallikrein-kinin system in experimental Chagas disease: A paradigm to investigate the impact of inflammatory edema on GPCRmediated pathways of host cell invasion by Trypanosoma cruzi
    • Scharfstein J, Andrade D, Svensjo E, Oliveira AC, Nascimento CR. 2012. The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCRmediated pathways of host cell invasion by Trypanosoma cruzi. Front. Immunol. 3:396. http://dx.doi.org/10. 3389/fimmu.2012.00396.
    • (2012) Front. Immunol. , vol.3 , pp. 396
    • Scharfstein, J.1    Andrade, D.2    Svensjo, E.3    Oliveira, A.C.4    Nascimento, C.R.5
  • 55
    • 0141671823 scopus 로고    scopus 로고
    • Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    • Berasain P, Carmona C, Frangione B, Cazzulo JJ, Goni F. 2003. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 130:23-29. http://dx.doi.org/10.1016/S0166-68511(03)00139-7.
    • (2003) Mol. Biochem. Parasitol. , vol.130 , pp. 23-29
    • Berasain, P.1    Carmona, C.2    Frangione, B.3    Cazzulo, J.J.4    Goni, F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.